Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | CrO4.2Na |
| Molecular Weight | 160.9219 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].[Na+].[O-][51Cr]([O-])(=O)=O
InChI
InChIKey=PXLIDIMHPNPGMH-PJWPDVOUSA-N
InChI=1S/Cr.2Na.4O/q;2*+1;;;2*-1/i1-1;;;;;;
| Molecular Formula | CrO4 |
| Molecular Weight | 114.9424 |
| Charge | -2 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | Na |
| Molecular Weight | 22.9898 |
| Charge | 1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Chromate ion CR-51 is a radioactive chromium 51 in the form of sterile, nonpyrogenic aqueous solution of sodium chromate. It is a diagnostic radiopharmaceutical for intravenous administration. This agent provides Chromium 51 decays by electron capture and gamma emission with a physical half-life of 27.7 days. It is indicated for use in determining red blood cell volume or mass, studying red blood cell survival time (in conditions such as hemolytic anemia), and evaluating blood loss. No adverse reactions specifically attributable to Chromate ion CR-51 injection have been reported.
Approval Year
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Diagnostic | SODIUM CHROMATE CR 51 Approved UseCr51 is indicated for use in determining red blood cell volume or mass, studying red blood cell survival time (in conditions such as hemolytic anemia), and evaluating blood loss Launch Date1971 |
|||
| Diagnostic | SODIUM CHROMATE CR 51 Approved UseCr51 is indicated for use in determining red blood cell volume or mass, studying red blood cell survival time (in conditions such as hemolytic anemia), and evaluating blood loss Launch Date1971 |
|||
| Diagnostic | SODIUM CHROMATE CR 51 Approved UseCr51 is indicated for use in determining red blood cell volume or mass, studying red blood cell survival time (in conditions such as hemolytic anemia), and evaluating blood loss Launch Date1971 |
Sample Use Guides
The usual doses to the average patient (70 kg) are as follows: Determination of red blood cell volume or mass–0.37 to 1.11 megabecquerels (10 to 30 microcuries).
Study of red blood cell survival time–5.55 megabecquerels (150 microcuries).
Evaluation of blood loss–7.40 megabecquerels (200 microcuries).
Route of Administration:
Intravenous
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:48:31 GMT 2023
by
admin
on
Fri Dec 15 15:48:31 GMT 2023
|
| Record UNII |
XI776WYU0N
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NDF-RT |
N0000177914
Created by
admin on Fri Dec 15 15:48:31 GMT 2023 , Edited by admin on Fri Dec 15 15:48:31 GMT 2023
|
||
|
NCI_THESAURUS |
C1446
Created by
admin on Fri Dec 15 15:48:31 GMT 2023 , Edited by admin on Fri Dec 15 15:48:31 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID20143241
Created by
admin on Fri Dec 15 15:48:31 GMT 2023 , Edited by admin on Fri Dec 15 15:48:31 GMT 2023
|
PRIMARY | |||
|
m10006
Created by
admin on Fri Dec 15 15:48:31 GMT 2023 , Edited by admin on Fri Dec 15 15:48:31 GMT 2023
|
PRIMARY | Merck Index | ||
|
3080662
Created by
admin on Fri Dec 15 15:48:31 GMT 2023 , Edited by admin on Fri Dec 15 15:48:31 GMT 2023
|
PRIMARY | |||
|
SUB15282MIG
Created by
admin on Fri Dec 15 15:48:31 GMT 2023 , Edited by admin on Fri Dec 15 15:48:31 GMT 2023
|
PRIMARY | |||
|
Sodium Chromate Cr 51
Created by
admin on Fri Dec 15 15:48:31 GMT 2023 , Edited by admin on Fri Dec 15 15:48:31 GMT 2023
|
PRIMARY | |||
|
546
Created by
admin on Fri Dec 15 15:48:31 GMT 2023 , Edited by admin on Fri Dec 15 15:48:31 GMT 2023
|
PRIMARY | |||
|
10039-53-9
Created by
admin on Fri Dec 15 15:48:31 GMT 2023 , Edited by admin on Fri Dec 15 15:48:31 GMT 2023
|
PRIMARY | |||
|
C47722
Created by
admin on Fri Dec 15 15:48:31 GMT 2023 , Edited by admin on Fri Dec 15 15:48:31 GMT 2023
|
PRIMARY | |||
|
CHEMBL2068575
Created by
admin on Fri Dec 15 15:48:31 GMT 2023 , Edited by admin on Fri Dec 15 15:48:31 GMT 2023
|
PRIMARY | |||
|
DB09380
Created by
admin on Fri Dec 15 15:48:31 GMT 2023 , Edited by admin on Fri Dec 15 15:48:31 GMT 2023
|
PRIMARY | |||
|
XI776WYU0N
Created by
admin on Fri Dec 15 15:48:31 GMT 2023 , Edited by admin on Fri Dec 15 15:48:31 GMT 2023
|
PRIMARY | |||
|
5106
Created by
admin on Fri Dec 15 15:48:31 GMT 2023 , Edited by admin on Fri Dec 15 15:48:31 GMT 2023
|
PRIMARY | |||
|
100000078087
Created by
admin on Fri Dec 15 15:48:31 GMT 2023 , Edited by admin on Fri Dec 15 15:48:31 GMT 2023
|
PRIMARY | |||
|
91510
Created by
admin on Fri Dec 15 15:48:31 GMT 2023 , Edited by admin on Fri Dec 15 15:48:31 GMT 2023
|
PRIMARY | RxNorm |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
NON-LABELED -> LABELED |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
